CPC09 Two cases of late-onset dystrophic epidermolysis bullosa COL7A1 mutations
Lisa O’Higgins,Jason Hynes,Cristina Grechin,Andrew Hudson,Muireann Roche,Marina O’Kane
DOI: https://doi.org/10.1093/bjd/ljae090.022
IF: 11.113
2024-06-28
British Journal of Dermatology
Abstract:Abstract Epidermolysis bullosa pruriginosa (EBP) is a highly distinctive phenotype of dystrophic EB (DEB). It is characterized by pruritic hypertrophic papules, nodules and plaques usually on the lower extremities. Clinical findings are caused by mutations in the COL7A1 gene on chromosome 3p21.3, which encodes type VII collagen. It is a rare condition that was first described in the literature in 1994 in a series of eight cases (McGrath JA, Schofield OM, Eady RA. Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. Br J Dermatol 1994; 130: 617–25). The condition usually presents in the neonatal period, during adolescence or early adulthood. There are < 100 documented cases to date (Kim WB, Alavi A, Pope E, Walsh S. Epidermolysis bullosa pruriginosa: case series and review of the literature. Int J Low Extrem Wounds 2015; 14: 196–9). Here, we present two cases of late-onset EBP. Case 1 is a 72-year-old woman with a 20-year history of a recalcitrant, pruritic violaceous eruption on her lower legs. Findings on biopsy were nonspecific, showing hyperkeratosis, mild epidermal spongiosis with a subepidermal split devoid of inflammatory cells. There was vascular proliferation in the superficial dermis and surrounding perivascular inflammation with an inflammatory infiltrate comprising lymphocytes, histiocytes and plasma cells. Differential diagnosis included venous stasis or DEB. Genetic sequencing was performed, revealing heterozygosity for a COL7A1 c.6007Gly>Arg mutation, confirming a diagnosis of autosomal dominant EBP. Case 2 is a 60-year-old woman who presented with pruritic coalescing nodules and papules. These had appeared initially on the buttocks and occipital scalp and subsequently developed on her wrists, elbows and lower legs. Hyperkeratotic toenails and a pincer nail on her left thumb were noted. A biopsy taken from her right thigh showed hyperkeratosis with acanthosis, and subepidermal cleavage containing mixed inflammatory cells. Genetic sequencing confirmed the heterozygous mutation IVS107–2delA in the COL7A1 gene, consistent with a variant of dystrophic EB highly suggestive of EBP. Both patients’ symptoms responded to dapsone. To our knowledge these mutations have not been reported elsewhere in the context of EBP. We highlight the potential for late onset of this rare condition, novel genetic mutations, and the role of genetic testing in situations of clinical uncertainty.
dermatology